India ramps up hepatitis elimination push, targets 2030 goal
- India aims to eliminate hepatitis as a public health threat by 2030
- Millions may be living with hepatitis B without knowing it, says liver transplant surgeon
- Dr Shubham Vatsya stresses need for early therapy and family awareness
- Barriers to hepatitis care being addressed through policy and outreach
National push against a silent epidemic
India has stepped up its campaign to eliminate hepatitis as a public health threat by 2030. The initiative targets both hepatitis B and C, which together affect a significant portion of the population.
Health authorities are focusing on early detection and treatment. Many carriers of the virus show no symptoms for years, making the disease a hidden burden.
Millions unaware of infection
A liver transplant surgeon has warned that millions of Indians may be living with hepatitis B without knowing it. The virus can quietly damage the liver over decades.
By the time symptoms appear, the disease often reaches an advanced stage. The surgeon explained why this silent virus is so dangerous—it can lead to cirrhosis or liver cancer if left untreated.
Expert calls for family-wide testing
Gastroenterologist Dr Shubham Vatsya has highlighted facts every family should know about hepatitis B and C. He stresses that the viruses can spread within households through shared items or from mother to child during birth.
Dr Vatsya recommends that all family members of an infected person get tested. Early diagnosis can prevent transmission and allow timely medical intervention.
Barriers to care persist
Despite progress, several barriers remain. A report in BusinessLine notes that stigma, lack of awareness, and limited access to testing centers keep many from seeking help.
Affordability of treatment is another issue, though generic drugs have brought costs down. The government is working to expand screening programs, especially in rural areas.
Why early therapy matters
The Times of India has reported cases where patients had no hepatitis B symptoms yet the disease had already progressed too far. This underscores why early therapy is critical.
Antiviral medications can suppress the virus and prevent liver damage. For hepatitis C, a cure is now possible with a short course of oral drugs.
What to watch
India's 2030 deadline is ambitious but achievable if testing and treatment reach the unreached. The coming months will see expanded screening drives and public awareness campaigns across states.